The enantiomer of allopregnanolone prevents pressure-mediated retinal degeneration via autophagy
Frontiers in Pharmacology
Open Access Publication
Rights and Permissions
Ishikawa M, Nakazawa T, Kunikata H, Sato K, Yoshitomi T, Krishnan K, Covey DF, Zorumski CF and Izumi Y (2022) The Enantiomer of Allopregnanolone Prevents Pressure-Mediated Retinal Degeneration Via Autophagy. Front. Pharmacol. 13:855779. doi: 10.3389/fphar.2022.855779 © 2022 Ishikawa, Nakazawa, Kunikata, Sato, Yoshitomi, Krishnan, Covey, Zorumski and Izumi. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
Ishikawa, Makoto; Nakazawa, Toru; Kunikata, Hiroshi; Sato, Kota; Yoshitomi, Takeshi; Krishnan, Kathiresan; Covey, Douglas F; Zorumski, Charles F; and Izumi, Yukitoshi, "The enantiomer of allopregnanolone prevents pressure-mediated retinal degeneration via autophagy." Frontiers in Pharmacology. 13, 855779 (2022).